UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II trial of paclitaxel and granulocyte colony-stimulating factor in patients with pancreatic carcinoma: a Southwest Oncology Group study

Journal of clinical oncology, 1997-06, Vol.15 (6), p.2414-2419

1997

Volltextzugriff (PDF)

Phase II Trial of High-Dose Intermittent Interleukin-2 in Metastatic Renal Cell Carcinoma: A Southwest Oncology Group Study

JNCI : Journal of the National Cancer Institute, 1990-01, Vol.82 (2), p.143-146

1990

Volltextzugriff (PDF)

Phase I trial of simultaneous administration of interleukin 2 and interleukin 4 subcutaneously

Clinical cancer research, 1995-10, Vol.1 (10), p.1145-1152

1995

Volltextzugriff (PDF)

Subcutaneous recombinant interleukin 2 in a dose escalating regimen in patients with metastatic renal cell adenocarcinoma

Cancer research (Chicago, Ill.), 1990-10, Vol.50 (20), p.6708-6715

1990

Volltextzugriff (PDF)

A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: A Southwest Oncology Group Study

Cancer, 2004-04, Vol.100 (8), p.1699-1704

2004

Volltextzugriff (PDF)

Chemotherapy Treatment of Chyloperitoneum and Peritoneal Carcinomatosis Due to Cervical Cancer—Review of Literature

Gynecologic oncology, 1996-06, Vol.61 (3), p.448-450

1996

Volltextzugriff (PDF)

Secondary syringomyelia due to intramedullary spinal cord metastasis : Case report and review of literature

American journal of clinical oncology, 1997-12, Vol.20 (6), p.577-579

1997

Volltextzugriff (PDF)

Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: a summary of the Southwest Oncology Group experience

Journal of immunotherapy, 1991-12, Vol.10 (6), p.426-431

1991

Volltextzugriff (PDF)

Three restriction endonucleases from Anabaena flos-aquae

Journal of general microbiology, 1985-04, Vol.131 (4), p.951-958

1985

Volltextzugriff (PDF)

A phase II trial of continuous-infusion recombinant interleukin-2 in patients with advanced renal cell carcinoma: a Southwest Oncology Group study

Journal of immunotherapy (1997), 1995-08, Vol.18 (2), p.104-114

1995

Volltextzugriff (PDF)

Treatment of Metastatic Renal Cell Carcinoma with Recombinant Interleukin-2 in Combination with Vinblastine or Lymphokine-Activated Killer Cells

The Journal of urology, 1993-09, Vol.150 (3), p.814-820

1993

Volltextzugriff (PDF)

A trial of vaccination with the carcinoembryonic antigen (CEA) peptide CAP 1–6D with montanide ISA 51 adjuvant or granulocyte- macrophage colony stimulating factor (GM-CSF) in HLA-A2+ patients with CEA producing adenocarcinomas of gastrointestinal (GI) track

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.13513-13513

2007

Volltextzugriff (PDF)

Evaluation and comparison of two commercially available targeted next-generation sequencing platforms to assist oncology decision making

OncoTargets and therapy, 2015-01, Vol.8 (default), p.959-967

2015

Volltextzugriff (PDF)

Phase II trial of recombinant human interleukin-4 in patients with disseminated malignant melanoma: a Southwest Oncology Group study

Journal of immunotherapy, 1998-11, Vol.21 (6), p.440-446

1998

Volltextzugriff (PDF)

A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: a Southwest oncology group (SWOG 9924) study

Investigational new drugs, 2005-10, Vol.23 (5), p.485-487

2005

Volltextzugriff (PDF)

SWOG S0727: A randomized phase II trial of combination gemcitabine plus erlotinib plus IMC-A12 (cixutumumab) versus gemcitabine plus erlotinib as first-line treatment in patients (pts) with metastatic pancreatic cancer

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.TPS223-TPS223

2010

Volltextzugriff (PDF)

A phase II study of chemotherapy of metastatic colorectal carcinoma with 5-fluorouracil plus cisplatin : a Southwest Oncology Group Study

Investigational new drugs, 1991-11, Vol.9 (4), p.345-347

1991

Volltextzugriff (PDF)

Phase II trial of CI-980 in patients with disseminated malignant melanoma and no prior chemotherapy : A Southwest Oncology Group study

Investigational new drugs, 2001-01, Vol.19 (3), p.239-243

2001

Volltextzugriff (PDF)

Diabetes mellitus in cancer patients treated with combination interleukin 2 and α-interferon

Cancer biotherapy, 1995, Vol.10 (1), p.45-51

1995

Volltextzugriff (PDF)

A phase II study of menogaril (NSC-269148) in colorectal carcinoma : a southwest oncology group study

Investigational new drugs, 1990-08, Vol.8 (3), p.295-297

1990

Volltextzugriff (PDF)

Nucleotide sequences at the ends of the mercury resistance transposon, Tn501

Nucleic acids research, 1980-05, Vol.8 (9), p.1933-1945

1980

Volltextzugriff (PDF)

A randomized phase III intergroup study of perioperative fluorouracil (5-FU) in patients with resectable colon cancer

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.3552-3552

2005

Volltextzugriff (PDF)

Phase II Study of Intravenous Bolus Recombinant Interleukin-2 in Advanced Malignant Melanoma: Southwest Oncology Group Study

JNCI : Journal of the National Cancer Institute, 1991-09, Vol.83 (17), p.1250-1252

1991

Volltextzugriff (PDF)

ECOG E3201: Intergroup randomized phase III study of postoperative irinotecan, 5- fluorouracil (FU), leucovorin (LV) (FOLFIRI) vs oxaliplatin, FU/LV (FOLFOX) vs FU/LV for patients (pts) with stage II/ III rectal cancer receiving either pre or postoperative radiation (RT)/ FU

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.3526-3526

2006

Volltextzugriff (PDF)

Phase II trial of depsipeptide (NSC-630176) in colorectal cancer patients who have received either one or two prior chemotherapy regimens for metastatic or locally advanced, unresectable disease: A Southwest Oncology Group study

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.3598-3598

2006

Volltextzugriff (PDF)

1 – 25 von 1.677

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.441)
Mit Volltextzugriff
(1.353)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.076)
Life Sciences & Biomedicine
(792)
Humans
(595)
Female
(344)
Biological And Medical Sciences
(328)
Male
(301)
Physical Sciences
(263)
Medical Sciences
(212)
Adult
(185)
Animals
(185)
Middle Aged
(175)
Fundamental And Applied Biological Sciences. Psychology
(131)
Physics
(130)
Aged
(128)
Adolescent
(108)
Technology
(103)
Oncology
(84)
Environmental Sciences & Ecology
(79)
Child
(72)
Exact Sciences And Technology
(72)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Phase II trial of paclitaxel and granulocyte colony-stimulating factor in patients with pancreatic carcinoma: a Southwest Oncology Group study

Phase II Trial of High-Dose Intermittent Interleukin-2 in Metastatic Renal Cell Carcinoma: A Southwest Oncology Group Study

Phase I trial of simultaneous administration of interleukin 2 and interleukin 4 subcutaneously

Subcutaneous recombinant interleukin 2 in a dose escalating regimen in patients with metastatic renal cell adenocarcinoma

A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: A Southwest Oncology Group Study

Chemotherapy Treatment of Chyloperitoneum and Peritoneal Carcinomatosis Due to Cervical Cancer—Review of Literature

Secondary syringomyelia due to intramedullary spinal cord metastasis : Case report and review of literature

Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: a summary of the Southwest Oncology Group experience

Three restriction endonucleases from Anabaena flos-aquae

A phase II trial of continuous-infusion recombinant interleukin-2 in patients with advanced renal cell carcinoma: a Southwest Oncology Group study

Treatment of Metastatic Renal Cell Carcinoma with Recombinant Interleukin-2 in Combination with Vinblastine or Lymphokine-Activated Killer Cells

A trial of vaccination with the carcinoembryonic antigen (CEA) peptide CAP 1–6D with montanide ISA 51 adjuvant or granulocyte- macrophage colony stimulating factor (GM-CSF) in HLA-A2+ patients with CEA producing adenocarcinomas of gastrointestinal (GI) track

Evaluation and comparison of two commercially available targeted next-generation sequencing platforms to assist oncology decision making

Phase II trial of recombinant human interleukin-4 in patients with disseminated malignant melanoma: a Southwest Oncology Group study

A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: a Southwest oncology group (SWOG 9924) study

SWOG S0727: A randomized phase II trial of combination gemcitabine plus erlotinib plus IMC-A12 (cixutumumab) versus gemcitabine plus erlotinib as first-line treatment in patients (pts) with metastatic pancreatic cancer

A phase II study of chemotherapy of metastatic colorectal carcinoma with 5-fluorouracil plus cisplatin : a Southwest Oncology Group Study

Phase II trial of CI-980 in patients with disseminated malignant melanoma and no prior chemotherapy : A Southwest Oncology Group study

Diabetes mellitus in cancer patients treated with combination interleukin 2 and α-interferon

A phase II study of menogaril (NSC-269148) in colorectal carcinoma : a southwest oncology group study

Nucleotide sequences at the ends of the mercury resistance transposon, Tn501

A randomized phase III intergroup study of perioperative fluorouracil (5-FU) in patients with resectable colon cancer

Phase II Study of Intravenous Bolus Recombinant Interleukin-2 in Advanced Malignant Melanoma: Southwest Oncology Group Study

ECOG E3201: Intergroup randomized phase III study of postoperative irinotecan, 5- fluorouracil (FU), leucovorin (LV) (FOLFIRI) vs oxaliplatin, FU/LV (FOLFOX) vs FU/LV for patients (pts) with stage II/ III rectal cancer receiving either pre or postoperative radiation (RT)/ FU

Phase II trial of depsipeptide (NSC-630176) in colorectal cancer patients who have received either one or two prior chemotherapy regimens for metastatic or locally advanced, unresectable disease: A Southwest Oncology Group study

Suchergebnisse filtern